Procaps Group SA Company Overview
About Procaps Group SA
Procaps Group SA (NASDAQ:PROC) operates in the pharmaceutical and health sector, focusing on developing, manufacturing, and marketing over-the-counter (OTC) pharmaceuticals and prescription drugs, along with advanced clinical nutrition products and supplements. Leveraging state-of-the-art technology, the company embraces a robust research and development approach to create innovative health solutions. With a global footprint, Procaps prioritizes expanding its reach in international markets through strategic partnerships, aiming to enhance access to affordable and high-quality healthcare products. The company is dedicated to sustainability and improving patient outcomes, aligning its projects and objectives with the broader goal of transforming the way healthcare is delivered around the world.
Snapshot
Operations
Products and/or services of Procaps Group SA
- Pharmaceutical Manufacturing: Procaps manufactures branded and generic prescription drugs across various therapeutic areas, including feminine care, pain relief, skin care, digestive health, and more.
- Over-the-Counter (OTC) Medications: They develop, manufacture, and market a wide range of OTC medications through their Colmed brand. These products cover various categories like vitamins, pain relievers, and gastrointestinal medications.
- Contract Development & Manufacturing Services (CDMO): Procaps offers CDMO services for the pharmaceutical, nutraceutical, and medical device industries. This involves working with clients to develop, manufacture, and package their products according to their specifications.
- Softgel Capsule Technology: Procaps specializes in softgel capsule technology, a type of dosage form for medications and nutritional supplements. They offer end-to-end solutions for softgel development, production, and delivery.
- Hospital Supplies: Procaps might also distribute or manufacture some essential hospital supplies, though the specific details might vary.
- Nutritional Supplements: Procaps potentially develops and manufactures nutritional supplements alongside their core pharmaceutical and OTC offerings.
Procaps Group SA executive team
- Mr. Jose Antonio Toledo VieiraChief Executive Officer
- Mr. Daniel BernalInterim Chief Financial Officer
- Dr. Camilo CamachoChief Operations Officer
- Ms. Melissa AngeliniInterim VP of Finance & Investor Relations Director
- Ms. Marcela Carvajalino PaganoVice-President of Corporate & Legal Affairs
- Mr. Luis Alberto Palacios AragonVice-President of International Marketing and R&D
- Mr. Mauricio Castaneda CaballeroVice-President of Human Resources
- Mr. Patricio Vargas MunozChief Optimization and Rationalization Officer